文献速递胸部肿瘤

变革肺癌结局的路线图:生物学、治疗创新、早期检测、预防与拦截的重点方向

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.
PubMed 文献 · Cancer Discov · 2026-01-01

本文由AACR肺癌工作组提出,旨在识别知识空白并规划未来研究重点,以降低肺癌发病率与死亡率。研究重点包括推进预防、加强早期检测、开发新疗法、优化患者分层、关注健康差异及被忽视亚型,并通过国际合作、集中临床试验数据库、新型试验设计和人工智能分析加速精准医学与耐药机制阐明。

要点

  • 肺癌仍是全球癌症死亡首因,需多维度研究优先事项协同推进
  • 重点领域包括预防、早期检测、新疗法、患者分层及健康差异
  • 国际合作与人工智能分析可加速精准医学和耐药机制研究

核心结论

  • 尽管靶向治疗、免疫治疗和早期检测取得进展,肺癌仍高度致命,需明确研究优先事项以改善结局。
  • AACR肺癌工作组提出涵盖预防、早期检测、治疗创新、患者分层、健康差异及被忽视亚型的研究路线图。
  • 国际合作、集中临床试验数据库、新型试验设计和人工智能分析有望加速精准医学和耐药机制阐明。

研究设计与样本

  • 本文为AACR肺癌工作组的立场文件,通过识别知识空白并提出未来研究优先领域。

主要发现

  • 靶向治疗、免疫治疗和早期检测的进步已革新肺癌治疗并延长生存,但肺癌仍高度致命。
  • 需推进预防倡议、加强早期检测策略、开发新疗法并优化患者分层。
  • 解决健康差异和增加对相对被忽视肺癌亚型的投入也至关重要。

临床怎么用

  • 临床应关注预防和早期检测策略的推进,并参与新型临床试验设计。
  • 在患者管理中重视分层优化及健康差异的解决。
  • 可利用国际合作和人工智能分析辅助精准医学实践和耐药机制研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Advances in targeted therapies, immunotherapy, and early detection have revolutionized lung cancer treatment and extended survival. Nonetheless, lung cancer remains highly fatal. Here, we identify knowledge gaps and propose critical areas of future research, aligning with the mission of the American Association for Cancer Research (AACR) Lung Cancer Task Force. We delineate research priorities, including advancing prevention initiatives, enhancing early detection strategies, developing novel treatments, and refining patient stratification. Addressing disparities and increasing efforts on relatively neglected lung cancer subtypes are also essential. Finally, international collaboration, centralized clinical trial databases, novel clinical trial designs, and artificial intelligence-driven analytics should accelerate precision medicine and aid in elucidating drug resistance mechanisms. Together, these efforts promise to improve patient outcomes. SIGNIFICANCE: Despite substantial progress in understanding disease biology and improving therapy, lung cancer remains the leading cause of global cancer-related deaths. The members of the AACR Lung Cancer Task Force describe areas of unmet need and define near-term research priorities and opportunities to reduce lung cancer morbidity and mortality.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Winslow MM, Ahmed MA, Berg CD, et al. A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception. Cancer Discov. 2026. PMID: 42001483. doi:10.1158/2159-8290.CD-25-2318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。